Patent · US Active

Substituted naphthalene sulfonamides

US7572787B2 · kind B2 · utility

2Cited by

1References

13Claims

0Family size

Assignee

Biovitrum AB · SE

Inventors

Patrizia Caldirola · Uppsala, SE
Ulf Bremberg · Upplands Väsby, SE
Gary Johansson · Hockessin, US
Andrew Mott · Knivsta, SE
Annika Jensen · Uppsala, SE
Katarina Beierlien · Uppsala, SE
Markus Thor · Knivsta, SE
Lars Tedenborg · Uppsala, SE

Key dates

Filing date	Aug 25, 2006
Grant date	Aug 11, 2009
Priority date	—
Expiry date	Aug 25, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D487/08
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to substituted sulfonamide compounds of the general formula (I), wherein P is sulfonamide or amide-substituted sulfonic acid, which compounds are potentially useful for the prophylaxis and treatment of medical conditions relating to obesity, type II diabetes and/or disorders of the central nervous system.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.